BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Mar 15, 2010
 |  BC Week In Review  |  Company News  |  Deals

Cellzome, GlaxoSmithKline deal

Business Inflammation

Cellzome and GlaxoSmithKline will use Cellzome's Episphere technology to discover small molecule candidates against undisclosed epigenetic targets to treat inflammatory diseases. Cellzome will receive €33 million...

Read the full 122 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >